The sacral chordoma margin

Area of Science:

• Oncology
• Surgical Oncology
• Radiation Oncology

Background:

• Chordoma is a rare bone neoplasm, frequently originating in the sacrum.
• Over 50% of sacral chordoma cases experience local recurrence after surgical treatment.

Purpose of the Study:

• To discuss strategies for optimizing surgical and radiation therapy margins in sacral chordoma.
• To report outcomes from the Chordoma Global Consensus Group meeting.
• To summarize recent evidence and future directions in sacral chordoma management.

Main Methods:

• Multidisciplinary consensus meeting focused on surgical, particle radiation therapy (RT), and medical therapies for chordoma.
• Review of current evidence and ongoing international clinical studies.
• Discussion of challenges in defining and achieving optimal margins.

Main Results:

• En-bloc tumor-sacrum resection is the primary surgical approach for sacral chordoma, aiming for negative margins.
• Radical particle RT shows comparable outcomes to surgery, but comparative trial data is limited.
• No current medical therapies are recommended for routine adjuvant or cytoreductive use.

Conclusions:

• Achieving negative margins is critical for local control in sacral chordoma.
• Standardized approaches to surgical resection and particle RT are vital for improving patient outcomes.
• Ongoing research, including comparative trials, is essential for refining treatment strategies.